Literature DB >> 9498740

Antigen-specific IgG responses from naive human splenocytes: in vitro priming followed by antigen boost in the SCID mouse.

P Brams1, M L Nguyen, S Chamat, I Royston, P R Morrow.   

Abstract

High titers of Ag-specific human IgG were consistently achieved in SCID mice reconstituted with human splenocytes that had been primed with Ag in vitro and then boosted with Ag after engraftment into SCID mice. Specific human IgG titers in the hu-SPL-SCID mice reached approximately 1:4 x 10(5) when the mice were immunized with a neo-antigen, whereas titers reached 1:2 x 10(6) when recall responses were induced. Booster immunizations with Ag 21 days after the initial in vivo boost further enhanced this response, and specific human IgG titers of 1:17 x 10(6) were achieved. This represented an essentially monospecific IgG population. These responses were CD4+ T cell dependent. In addition, affinity maturation of the human Ab responses was observed. Spleens of hu-SPL-SCID mice with Ag-specific titers < or = 1:1 x 10(6) were often significantly enlarged and often displayed visible tumors. Fourteen of sixteen B cell tumors removed from spleens of five such hu-SPL-SCID mice, produced Abs that were specific for the immunizing Ags. From such tumor, cloned cell lines were established. One such mAb, MLN-7 (gamma1, kappa), was raised to tetanus toxoid and had no identified cross-reactivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498740

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.

Authors:  Arnone Nithichanon; Louise J Gourlay; Gregory J Bancroft; Manabu Ato; Yoshimasa Takahashi; Ganjana Lertmemongkolchai
Journal:  Immunology       Date:  2017-02-09       Impact factor: 7.397

2.  In vivo antigen-driven plasmablast enrichment in combination with antigen-specific cell sorting to facilitate the isolation of rare monoclonal antibodies from human B cells.

Authors:  Zhonghua Lin; Nancy Y Chiang; Ning Chai; Dhaya Seshasayee; Wyne P Lee; Mercedesz Balazs; Gerald Nakamura; Lee R Swem
Journal:  Nat Protoc       Date:  2014-06-05       Impact factor: 13.491

3.  Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization.

Authors:  C Heard; P Brams; E Walsh; T Huynh; S Chamat; M Reff; A Owyang; W Shestowsky; R Newman
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

4.  Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.

Authors:  H Nguyen; J Hay; T Mazzulli; S Gallinger; J Sandhu; Y Teng; N Hozumi
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

5.  Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice.

Authors:  Andrew J Murphy; Lynn E Macdonald; Sean Stevens; Margaret Karow; Anthony T Dore; Kevin Pobursky; Tammy T Huang; William T Poueymirou; Lakeisha Esau; Melissa Meola; Warren Mikulka; Pamela Krueger; Jeanette Fairhurst; David M Valenzuela; Nicholas Papadopoulos; George D Yancopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-25       Impact factor: 11.205

6.  Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.

Authors:  Stéphanie Ghosn; Soulaima Chamat; Eric Prieur; Antoine Stephan; Pierre Druilhe; Hasnaa Bouharoun-Tayoun
Journal:  Front Immunol       Date:  2018-03-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.